Physician profile
William Grigg
NPI 1578050266
$53,166.15
in general payments reported to CMS, 2019-2025
16 companies · $45K in 2025
The $45K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $1,983 · 2023: $4,276 · 2024: $2,229 · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $35K · Travel and Lodging: $11K · Food and Beverage: $4,591 · Education: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $35,000.00 |
| Travel and Lodging | $11,186.30 |
| Food and Beverage | $4,591.29 |
| Education | $293.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24,141.99 | 2022-2025 | Advisa Dr Mri Surescan, Micra, Arctic Front Advance |
| Boston Scientific Corporation | $20,739.56 | 2022-2025 | Emblem Mri S-Icd, Farapulse, Watchman Access System |
| Abbott Laboratories | $5,909.15 | 2022-2025 | Ensite, Gallant, Ensite Precision |
| Biosense Webster, INC. | $1,817.03 | 2022-2025 | Carto 3 |
| Medical Device Business Services, INC. | $149.81 | 2022 | |
| Astellas Pharma US INC | $92.99 | 2021 | |
| Biotronik INC. | $59.73 | 2024 | Acticor 7 Vr-T Dx, Renamic Neo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.13 | 2022-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $39.74 | 2023 | Xarelto |
| Cardiva Medical, INC. | $32.19 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Amgen INC. | $32.07 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $27.99 | 2023 | |
| Alnylam Pharmaceuticals INC. | $26.58 | 2023 | Amvuttra |
| Abiomed | $21.24 | 2022 | |
| Edwards Lifesciences Corporation | $15.71 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $13.24 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Grigg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.